Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

Thorgeir E Thorgeirsson; Daniel F Gudbjartsson; Ida Surakka; Jacqueline M Vink; Najaf Amin; Frank Geller; Patrick Sulem; Thorunn Rafnar; Tõnu Esko; Stefan Walter; Christian Gieger; Rajesh Rawal; Massimo Mangino; Inga Prokopenko; Reedik Mägi; Kaisu Keskitalo; Iris H Gudjonsdottir; Solveig Gretarsdottir; Hreinn Stefansson; John R Thompson; Yurii S Aulchenko; Mari Nelis; Katja K Aben; Martin den Heijer; Asger Dirksen; Haseem Ashraf; Nicole Soranzo; Ana M Valdes; Claire Steves; André G Uitterlinden; Albert Hofman; Anke Tönjes; Peter Andreas Lehn Kovacs; Jouke Jan Hottenga; Gonneke Willemsen; Nicole Vogelzangs; Angela Döring; Norbert Dahmen; Barbara Nitz; Michele L Pergadia; Berta Saez; Veronica De Diego; Victoria Lezcano; Maria D Garcia-Prats; Samuli Ripatti; Markus Perola; Johannes Kettunen; Anna-Liisa Hartikainen; Anneli Pouta; Jesper Holst Pedersen; ENGAGE Consortium

doi:10.1038/ng.573

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

Thorgeir E Thorgeirsson, Daniel F Gudbjartsson, Ida Surakka, Jacqueline M Vink, Najaf Amin, Frank Geller, Patrick Sulem, Thorunn Rafnar, Tõnu Esko, Stefan Walter, Christian Gieger, Rajesh Rawal, Massimo Mangino, Inga Prokopenko, Reedik Mägi, Kaisu Keskitalo, Iris H Gudjonsdottir, Solveig Gretarsdottir, Hreinn Stefansson, John R ThompsonYurii S Aulchenko, Mari Nelis, Katja K Aben, Martin den Heijer, Asger Dirksen, Haseem Ashraf, Nicole Soranzo, Ana M Valdes, Claire Steves, André G Uitterlinden, Albert Hofman, Anke Tönjes, Peter Andreas Lehn Kovacs, Jouke Jan Hottenga, Gonneke Willemsen, Nicole Vogelzangs, Angela Döring, Norbert Dahmen, Barbara Nitz, Michele L Pergadia, Berta Saez, Veronica De Diego, Victoria Lezcano, Maria D Garcia-Prats, Samuli Ripatti, Markus Perola, Johannes Kettunen, Anna-Liisa Hartikainen, Anneli Pouta, Jesper Holst Pedersen, ENGAGE Consortium

Lungemedicinsk afd

588 Citationer (Scopus)

Abstract

Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P <5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).

Originalsprog	Engelsk
Tidsskrift	Nature Genetics
Vol/bind	42
Udgave nummer	5
Sider (fra-til)	448-53
Antal sider	6
ISSN	1061-4036
DOI	https://doi.org/10.1038/ng.573
Status	Udgivet - 1 maj 2010

Adgang til dokumentet

10.1038/ng.573

Citationsformater

Thorgeirsson, T. E., Gudbjartsson, D. F., Surakka, I., Vink, J. M., Amin, N., Geller, F., Sulem, P., Rafnar, T., Esko, T., Walter, S., Gieger, C., Rawal, R., Mangino, M., Prokopenko, I., Mägi, R., Keskitalo, K., Gudjonsdottir, I. H., Gretarsdottir, S., Stefansson, H., ... ENGAGE Consortium (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics, 42(5), 448-53. https://doi.org/10.1038/ng.573

Thorgeirsson, TE, Gudbjartsson, DF, Surakka, I, Vink, JM, Amin, N, Geller, F, Sulem, P, Rafnar, T, Esko, T, Walter, S, Gieger, C, Rawal, R, Mangino, M, Prokopenko, I, Mägi, R, Keskitalo, K, Gudjonsdottir, IH, Gretarsdottir, S, Stefansson, H, Thompson, JR, Aulchenko, YS, Nelis, M, Aben, KK, den Heijer, M, Dirksen, A, Ashraf, H, Soranzo, N, Valdes, AM, Steves, C, Uitterlinden, AG, Hofman, A, Tönjes, A, Kovacs, PAL, Hottenga, JJ, Willemsen, G, Vogelzangs, N, Döring, A, Dahmen, N, Nitz, B, Pergadia, ML, Saez, B, De Diego, V, Lezcano, V, Garcia-Prats, MD, Ripatti, S, Perola, M, Kettunen, J, Hartikainen, A-L, Pouta, A, Pedersen, JH & ENGAGE Consortium 2010, 'Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior', Nature Genetics, bind 42, nr. 5, s. 448-53. https://doi.org/10.1038/ng.573

@article{380f901d5a274afb85346198cb3b0736,

title = "Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior",

abstract = "Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P <5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).",

author = "Thorgeirsson, {Thorgeir E} and Gudbjartsson, {Daniel F} and Ida Surakka and Vink, {Jacqueline M} and Najaf Amin and Frank Geller and Patrick Sulem and Thorunn Rafnar and T{\~o}nu Esko and Stefan Walter and Christian Gieger and Rajesh Rawal and Massimo Mangino and Inga Prokopenko and Reedik M{\"a}gi and Kaisu Keskitalo and Gudjonsdottir, {Iris H} and Solveig Gretarsdottir and Hreinn Stefansson and Thompson, {John R} and Aulchenko, {Yurii S} and Mari Nelis and Aben, {Katja K} and {den Heijer}, Martin and Asger Dirksen and Haseem Ashraf and Nicole Soranzo and Valdes, {Ana M} and Claire Steves and Uitterlinden, {Andr{\'e} G} and Albert Hofman and Anke T{\"o}njes and Kovacs, {Peter Andreas Lehn} and Hottenga, {Jouke Jan} and Gonneke Willemsen and Nicole Vogelzangs and Angela D{\"o}ring and Norbert Dahmen and Barbara Nitz and Pergadia, {Michele L} and Berta Saez and {De Diego}, Veronica and Victoria Lezcano and Garcia-Prats, {Maria D} and Samuli Ripatti and Markus Perola and Johannes Kettunen and Anna-Liisa Hartikainen and Anneli Pouta and Pedersen, {Jesper Holst} and {ENGAGE Consortium}",

year = "2010",

month = may,

day = "1",

doi = "10.1038/ng.573",

language = "English",

volume = "42",

pages = "448--53",

journal = "Nature Genetics",

issn = "1061-4036",

publisher = "Nature Research",

number = "5",

}

TY - JOUR

T1 - Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

AU - Thorgeirsson, Thorgeir E

AU - Gudbjartsson, Daniel F

AU - Surakka, Ida

AU - Vink, Jacqueline M

AU - Amin, Najaf

AU - Geller, Frank

AU - Sulem, Patrick

AU - Rafnar, Thorunn

AU - Esko, Tõnu

AU - Walter, Stefan

AU - Gieger, Christian

AU - Rawal, Rajesh

AU - Mangino, Massimo

AU - Prokopenko, Inga

AU - Mägi, Reedik

AU - Keskitalo, Kaisu

AU - Gudjonsdottir, Iris H

AU - Gretarsdottir, Solveig

AU - Stefansson, Hreinn

AU - Thompson, John R

AU - Aulchenko, Yurii S

AU - Nelis, Mari

AU - Aben, Katja K

AU - den Heijer, Martin

AU - Dirksen, Asger

AU - Ashraf, Haseem

AU - Soranzo, Nicole

AU - Valdes, Ana M

AU - Steves, Claire

AU - Uitterlinden, André G

AU - Hofman, Albert

AU - Tönjes, Anke

AU - Kovacs, Peter Andreas Lehn

AU - Hottenga, Jouke Jan

AU - Willemsen, Gonneke

AU - Vogelzangs, Nicole

AU - Döring, Angela

AU - Dahmen, Norbert

AU - Nitz, Barbara

AU - Pergadia, Michele L

AU - Saez, Berta

AU - De Diego, Veronica

AU - Lezcano, Victoria

AU - Garcia-Prats, Maria D

AU - Ripatti, Samuli

AU - Perola, Markus

AU - Kettunen, Johannes

AU - Hartikainen, Anna-Liisa

AU - Pouta, Anneli

AU - Pedersen, Jesper Holst

AU - ENGAGE Consortium

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P <5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).

AB - Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P <5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).

U2 - 10.1038/ng.573

DO - 10.1038/ng.573

M3 - Journal article

C2 - 20418888

SN - 1061-4036

VL - 42

SP - 448

EP - 453

JO - Nature Genetics

JF - Nature Genetics

IS - 5

ER -

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater